Jiangang Liu

ORCID: 0000-0003-2346-656X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Kruppel-like factors research
  • Phagocytosis and Immune Regulation
  • Cell Adhesion Molecules Research
  • FOXO transcription factor regulation
  • Virus-based gene therapy research
  • Cancer, Hypoxia, and Metabolism
  • Chronic Myeloid Leukemia Treatments
  • Ginkgo biloba and Cashew Applications
  • Cancer Research and Treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Radiomics and Machine Learning in Medical Imaging
  • Air Quality and Health Impacts
  • Advanced Glycation End Products research
  • Transportation Planning and Optimization
  • Medical Imaging Techniques and Applications
  • Immune cells in cancer
  • MRI in cancer diagnosis
  • Neurological Disease Mechanisms and Treatments
  • Ferroptosis and cancer prognosis
  • Mitochondrial Function and Pathology
  • Natural Compounds in Disease Treatment
  • Pancreatic function and diabetes
  • Genetic and Kidney Cyst Diseases
  • Nanoparticle-Based Drug Delivery
  • Genomics and Chromatin Dynamics

Beihang University
2025

Ministry of Industry and Information Technology
2025

Southern Medical University Shenzhen Hospital
2017-2022

Third Affiliated Hospital of Southern Medical University
2022

Chinese Academy of Medical Sciences & Peking Union Medical College
2018

Xiyuan Hospital
2018

Affiliated Hospital of Taishan Medical University
2018

SAIC Motor (China)
2017

Soochow University
2012

First Affiliated Hospital of Soochow University
2012

Polydatin (PD), a resveratrol glycoside, has been shown to protect renal function in diabetic nephropathy (DN), but the underlying molecular mechanism remains unclear. This study demonstrates that PD stabilize mitochondrial morphology and attenuate malfunction both KKAy mice hyperglycemia (HG)‐induced MPC5 cells. We use Western blot analysis demonstrate reversed podocyte apoptosis induced by HG via suppressing dynamin‐related protein 1 (Drp1). effect may depend on ability of inhibit...

10.1002/jcp.25943 article EN cc-by Journal of Cellular Physiology 2017-04-06

The role of celastrol in the treatment cancer has been an area growing interest. To circumvent issues low solubility, poor bioavailability, and systemic toxicity celastrol, we prepared liposomal using thin-film dispersion method. We characterized particle size, encapsulation efficiency, pharmacological parameters celastrol. drug concentration plasma tissues was measured LC-MS/MS. In addition, sulforhodamine B assay used to determine 50% inhibiting concentration. assessed effects compound...

10.1097/cad.0b013e3283514b68 article EN Anti-Cancer Drugs 2012-02-16

Early prediction of treatment response to neoadjuvant therapy (NAT) in breast cancer patients can facilitate timely adjustment regimens. We aimed develop and validate a MRI-based enhanced self-attention network (MESN) for predicting pathological complete (pCR) based on longitudinal images at the early stage NAT. Two imaging datasets were utilized: subset from ACRIN 6698 trial (dataset A, n = 227) prospective collection Chinese hospital B, 245). These divided into three cohorts: an training...

10.1186/s13058-025-02009-6 article EN cc-by-nc-nd Breast Cancer Research 2025-04-03

Background High-grade gliomas are rapidly progressing tumors of the central nervous system, and associated with poor prognosis highly immunosuppressive microenvironments. Meanwhile, a better understanding PD-L1, major prognostic biomarker for checkpoint immune therapy, regulation may provide insights developing novel immunotherapeutic strategies treating gliomas. In present study, we elucidate functional significance orphan nuclear receptor TLX in human glioma, its role suppression through...

10.1136/jitc-2020-001937 article EN cc-by-nc Journal for ImmunoTherapy of Cancer 2021-04-01

Acute myocardial infarction (AMI) is one of the most threaten disease in world. Ginkgetin aglycone (GA) was a new kind Ginkgo biloba, involved various diseases, including kidney injury and acute pancreatitis. However, function GA AMI remains unknown. The aim study to investigate characteristics ischemic-reperfusion injury.H2 O 2 - CoCl -treated H9C2 cells were used analyze vitro. Caspase 3, interleukin-6 (IL-6), tumor necrosis factor-α detected evaluate apoptosis inflammation response. Rat...

10.1002/jcb.28086 article EN Journal of Cellular Biochemistry 2018-12-23

Abstract Our previous study illustrated that nuclear factor IX (NFIX) promotes glioblastoma (GBM) progression by inducing migration and proliferation of GBM cells. However, the underlying mechanism how NFIX regulates cell remains obscure. In this study, we uncovered Go-Ichi-Ni-San 1 (GINS1) is upregulated positively correlated with in human specimen. silencing downregulates expression GINS1, which pivotal for cell-cycle Replenishment GINS1 largely rescues NFIX-null effect on proliferation....

10.1158/1541-7786.mcr-22-0504 article EN Molecular Cancer Research 2022-12-05

<p>S1. Full images of immunoblotting. S2. NFIX knockdown has no effect on p53 and p21 expression. S3. Knockdown GINS1 by shRNAs in U87 cells. S4. represses proliferation GL261 cells S5. rescues the delayed growth NFIX-null tumor. S6. directly up-regulated gene occupying its promoter</p>

10.1158/1541-7786.22527983 preprint EN cc-by 2023-04-03

<p>S1. Full images of immunoblotting. S2. NFIX knockdown has no effect on p53 and p21 expression. S3. Knockdown GINS1 by shRNAs in U87 cells. S4. represses proliferation GL261 cells S5. rescues the delayed growth NFIX-null tumor. S6. directly up-regulated gene occupying its promoter</p>

10.1158/1541-7786.22527983.v1 preprint EN cc-by 2023-04-03

<div>Abstract<p>Our previous study illustrated that nuclear factor IX (NFIX) promotes glioblastoma (GBM) progression by inducing migration and proliferation of GBM cells. However, the underlying mechanism how NFIX regulates cell remains obscure. In this study, we uncovered Go-Ichi-Ni-San 1 (GINS1) is upregulated positively correlated with in human specimen. silencing downregulates expression GINS1, which pivotal for cell-cycle Replenishment GINS1 largely rescues NFIX-null effect...

10.1158/1541-7786.c.6545582 preprint EN 2023-04-03

<div>Abstract<p>Our previous study illustrated that nuclear factor IX (NFIX) promotes glioblastoma (GBM) progression by inducing migration and proliferation of GBM cells. However, the underlying mechanism how NFIX regulates cell remains obscure. In this study, we uncovered Go-Ichi-Ni-San 1 (GINS1) is upregulated positively correlated with in human specimen. silencing downregulates expression GINS1, which pivotal for cell-cycle Replenishment GINS1 largely rescues NFIX-null effect...

10.1158/1541-7786.c.6545582.v1 preprint EN 2023-04-03

Objective: To investigate the inhibitory effect of polyethylene glycol modified magnetic 5-fluorouracil albumin microspheres (PEG-5-FU-MAMS) combined with external constant fields on LoVo colon cancer cells in vitro and mechanism. Methods: The PEG-5-FU-MAMS were prepared by emulsification/solidification method. cultured divided into four groups. Group A was fields; group B pure without C free 5- fluorouracil (5-FU); D magnet. growth observed under an inverted microscopy rate (IR) assayed...

10.4066/biomedicalresearch.29-18-1120 article EN Biomedical Research - India 2018-01-01
Coming Soon ...